Regulatory Affairs and Clinical Operations Vice Presidents Add Key Expertise as Company Prepares to Initiate U.S. Clinical Trials November 30, 2022 – Seattle, Boston and Tokyo – Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Sherita Hall as vice president, clinical operations...
As others have said both are valid and will do the trick. I'm not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.
As others have said both are valid and will do the trick. I'm not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.
As others have said both are valid and will do the trick. I'm not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.